H1N1 Flu Vaccine: Two Dose Levels in HIV positive volunteers
A Phase II Study in HIV - seropositive Adults to Assess the Safety and Immunogenicity of an Unadjuvanted Novartis H1N1 Influenza Vaccine Administered at Two Dose Levels (DMID Prot ocol Numb er: 09 - 0073 )